Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Natera OncologyNatera Oncology
VS
AvantorAvantor
Natera Oncology

Natera Oncology

13011A McCallen Pass , Austin, TX, 78753, US

Last Update: 03/11/2025

View Profile

Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer. Follow us on Twitter: @NateraOncology

NAICS:541
NAICS Definition:N/A
Employees:0
Subsidiaries:3
12-month incidents
0
Known data breaches
0
Attack type number
0
Avantor

Avantor

100 Matsonford Rd, Radnor Township, US

Last Update: 31/03/2026

View Profile
Between 750 and 799
http://avantorsciences.com
776/1000Fair

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most impo...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:12,594
Subsidiaries:4
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Natera Oncology

Natera Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Avantor

Avantor

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Natera Oncology in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Avantor in 2026.

Incidents

Incident History - Natera Oncology (X = Date, Y = Severity)

Natera Oncology cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Avantor (X = Date, Y = Severity)

Avantor cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Natera Oncology

Natera Oncology

Incidents
No explicit notable incidents reported.
Avantor

Avantor

Incidents
No explicit notable incidents reported.

FAQ

Between Natera Oncology company and Avantor company, which one has the best AI Cybersecurity Score ?
Between Natera Oncology company and Avantor company, which one has experienced more cyber incidents in the past ?
Between Natera Oncology company and Avantor company, which one has experienced more cyber incidents this year ?
Between Natera Oncology company and Avantor company, which one has experienced at least one ransomware attack ?
Between Natera Oncology company and Avantor company, which one has experienced at least one data breach ?
Between Natera Oncology company and Avantor company, which one has experienced at least one targeted cyberattack ?
Between Natera Oncology company and Avantor company, which one has experienced at least one vulnerability ?
Between Natera Oncology company and Avantor company, which one holds the most compliance certifications ?
Between Natera Oncology company and Avantor company, which one holds the fewest compliance certifications ?
Between Natera Oncology company and Avantor company, which one has the most subsidiaries ?
Between Natera Oncology company and Avantor company, which one has the largest number of employees ?
Between Natera Oncology and Avantor, which company holds both SOC 2 Type 1 certifications ?
Between Natera Oncology and Avantor, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Natera Oncology or Avantor ?
Which company is PCI DSS compliant - Natera Oncology or Avantor ?
Between Natera Oncology and Avantor, which company complies with HIPAA regulations for healthcare data ?
Between Natera Oncology and Avantor, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-86544
SUMMARY

knowns versions before 0.30.0 contain an authorization bypass vulnerability where mutating code actions are incorrectly classified as read-only operations. Attackers with read-restricted sessions can exploit code.replace to modify permission configurations and escalate privileges on subsequent calls.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86543
SUMMARY

knowns versions before 0.30.0 serve the management API without authentication on all network interfaces by default, with no password required on fresh installations. Attackers can access the unauthenticated /api/tunnel/start endpoint to provision a public tunnel and republish the API at a publicly accessible address.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-86542
SUMMARY

knowns before 0.30.0 fails to validate import names in the import routes, allowing unauthenticated attackers to write files outside the imports directory. Attackers can supply traversal sequences in the name parameter to escape the imports directory and overwrite arbitrary files writable by the server process.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-86541
SUMMARY

knowns versions before 0.30.0 contain a path traversal vulnerability in the handleCodeReplace() function that allows attackers to overwrite arbitrary files outside the project root. Attackers can supply absolute paths or relative paths containing directory traversal sequences to write malicious content to sensitive files like shell startup scripts or SSH configuration files.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.3)
CVSS3
Base Score: 8.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.5
EXPLOITABILITY
2.8
CVE-2026-86540
SUMMARY

knowns versions before 0.30.0 fail to validate the settings.lsp.languages binary field in project configuration files, allowing attackers to execute arbitrary binaries by crafting a malicious .knowns/config.json file. When a repository with a crafted configuration is opened, the unvalidated binary path is executed twice under the user's account without any verification.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.5
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
1.8